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ABSTRACT
The cellular response to hypoxia is characterised by
a switch in the transcriptional program, mediated
predominantly by the hypoxia inducible factor fam-
ily of transcription factors (HIF). Regulation of HIF1
is primarily controlled by post-translational modifica-
tion of the HIF1 subunit, which can alter its stability
and/or activity. This study identifies an unanticipated
role for the X-linked inhibitor of apoptosis (XIAP)
protein as a regulator of Lys63-linked polyubiquitina-
tion of HIF1 . Lys63-linked ubiquitination of HIF1 by
XIAP is dependent on the activity of E2 ubiquitin con-
jugating enzyme Ubc13. We find that XIAP and Ubc13
dependent Lys63-linked polyubiquitination promotes
HIF1 nuclear retention leading to an increase in
the expression of HIF1 responsive genes. Inhibition
of the Lys63-linked polyubiquitination pathway leads
to reduced levels of nuclear HIF1 , promoter occu-
pancy, HIF-dependent gene expression and cell via-
bility. Our data reveals an additional and significant
level of control of the HIF1 by XIAP, with important
implications in understanding the role of HIF1 and
XIAP in human disease.
INTRODUCTION
Hypoxia is the consequence of a failure in oxygen delivery
to cells, either as a result of reduced oxygen partial pres-
sures, or disruption to the circulating blood supply (1). Cel-
lular signalling pathways have evolved to enable organisms
to adapt to the changing environment and maintain oxygen
homeostasis when oxygen levels are limiting (1,2). At the
cellular level the response to hypoxia is characterised by a
switch in the transcriptional program, resulting in changes
in the expression of a large number of genes (1). The main
mediator of these changes in gene expression is hypoxia in-
ducible factor (HIF), a family of transcription factors that
play key roles in development, physiological processes and
pathological conditions (1,2).
The best-characterised form of HIF, HIF1, is a het-
erodimeric transcription factor composed of HIF1 and
HIF1 subunits (2). HIF1 is primarily regulated through
the stability of the HIF1 subunit, which is controlled
by the action of several proline hydroxylases (PHDs) (3).
Following hydroxylation, HIF1 is recognised by the von
Hippel-Lindau (VHL) E3 ubiquitin ligase, which promotes
the ubiquitination and subsequent degradation of HIF1
by the 26S proteasome (4). The PHDs are inactivated when
oxygen levels are reduced, resulting in HIF1 stabilisation
and accumulation in the nucleus where it can dimerise with
HIF1 to activate target gene expression (5).
Ubiquitination, the covalent attachment of ubiquitin
to target proteins, is one of the most versatile post-
translational modifications in the cell as it can modify sub-
strate proteins in its monomeric form (monoubiquitination)
or be conjugated in the form of ubiquitin chains (polyubiq-
uitination) (6,7). Homogenous, mixed, linear or branched
polyubiquitin chains can be generated through successive
isopeptide bond formation using any of the seven internal
lysines, positioned at amino acid residues 6, 11, 27, 29, 33,
48 and 63, or the initiator methionine (7). Different ubiq-
uitin chain linkages result in distinct polyubiquitin chain
topologies creating a range of molecular signals that encode
information about the substrate’s fate in the cell (7,8).
VHL-dependent regulation of HIF1 is well described,
however it is not the only E3 ubiquitin ligase or ubiquitin-
mediated mechanism through which HIF1 is regulated.
In hypoxic cells ubiquitin chains heavily modify HIF1,
even though the action of VHL is inhibited. Consistent
with these observations, unbiased mass spectrometry ex-
periments reveal 25 lysine residues on HIF1 are modi-
fied by ubiquitin in cells, but only three of these are re-
quired for VHL-dependent degradation (http://thebiogrid.
org/109338/protein) (9).
Here we describe a novel, unanticipated role for XIAP,
an E3 ubiquitin ligase, in the regulation of HIF1 follow-
ing hypoxic stress. Depletion of XIAP results in an impaired
nuclear accumulation of HIF1 and a resultant decrease in
the transactivation of HIF1 target genes. XIAP-dependent
regulation of HIF1 is independent of HIF1 stabilisa-
tion; instead XIAP directly ubiquitinates HIF1 in a Lys63-
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dependent manner. In addition specific inhibitors of the
Lys63-ubiquitin conjugation pathway suppress the HIF1-
dependent hypoxic response and sensitise cells to hypoxic
stress. Our findings suggest that targetingLys63-linked ubiq-
uitination of HIF1 could be used as a therapeutic strategy
for diseases with aberrant HIF activity.
MATERIALS AND METHODS
Cell lines and culture conditions
U2OS, HEK293 and RCC4 cell lines were grown in Dul-
becco’s modified eagle medium (Lonza) supplemented with
10% fetal bovine serum (Gibco) and glutamate (Gibco).
PC-3 cells were grown in RPMI 1640 medium supple-
mented with 10% fetal bovine serum and glutamate.
Treatments
NSC697923 (Sigma), MG132 (Calbiochem), BAY 11-8042
(Calbiochem) and Leptomycin B (Sigma) were prepared in
DMSO and added to cells at the concentrations indicated
in the figure legends.
DNA constructs and transfections
pcDNA3-HA-HIF1 (Addgene #18949), pcDNA3-HA-
HIF1 P402A P562A (Addgene #18955), pcDNA3-
HA-PHD1 (Addgene #18961), pcDNA3-PHD2 (Ad-
dgene #19963), pcDNA3-PHD3 (Addgene #18960),
pRc/CMV-HA-VHL (Addgene #19999) were gifts
from William Kaelin supplied by Addgene. pEBB-His-
ubiquitin, pEBB-FLAG-XIAP, pEBB-FLAG-VHL
(subcloned from pRc/CMV-HA-VHL into pEBB-
Flag), pEBB-N-biotin-HIF-1, pET15-ubiquilin TUBE
(DU 20108 MRCPPU reagents, University of Dundee
[mrcppureagents.dundee.ac.uk]), pET28a-6xHis-TAB2 aa
644–692 dimer (DU 23839 MRCPPU reagents), pET28a-
6xHis-TAB2 aa 644–692 dimer T674A F675A (DU
46083 MRCPPU reagents). HEK293 transfections were
performed using a standard calcium phosphate method.
Transfections into U2OS cells were performed using
GeneJuice (Invitrogen) according to the manufacturer’s
instructions.
siRNA transfection
siRNA duplex oligonucleotides were synthesised by
MWG and transfected using Interferin (Polyplus) ac-
cording to the manufacturer’s instructions. siRNA
sequences: control––CAG UCG CGU UUG CGA CUG
G; XIAP #A––GUG GUA GUC CUG UUU CAG
C; XIAP #B––GGA GAU ACC GUG CGG UGC
U; HIF1––GCA UAU AUC UAG AAG GUA U;
Ubc13-GGC UAU AUG CCA UGA AUA A.
Immunoblotting and antibodies
Cell lysates were prepared with modified RIPA lysis buffer
(50 mM Tris pH 8.0, 150 mM NaCl, 1% NP40, 0.5%
C24H39NaO4, 0.1% SDS) supplemented with protease in-
hibitors and incubated on ice for 15 min. Lysates were then
sonicated in a Biodisrupter Ultra-Sonic Waterbath (Di-
agenode) (2 × 30 s cycles on high) to shear the genomic
DNA and clarified by centrifugation at 13 000 rpm at 4◦C
for 10 min.
Nuclear and cytoplasmic extracts were prepared from a
single sub-confluent 10 cm dish of U2OS cells for each con-
dition. Briefly, cells were washed once with PBS and scraped
into 1 ml ice cold hypotonic buffer and incubated on ice
for 5 min before being lysed by 10 strokes of a Dounce
homogeniser. Extracts were centrifuged for 10 min at 13
000 rpm 4◦C and the supernatant (cytoplasmic extract) re-
moved. The pellet (nuclei) was washed once with hypotonic
buffer before being resuspended in 100 l of hypertonic
buffer. Lysates were then sonicated in a Biodisrupter Ultra-
Sonic Waterbath (Diagenode) (2 × 30 s cycles on high) to
shear the genomic DNA and clarified by centrifugation at
13 000 rpm at 4◦C for 10 min and the nuclear extracts col-
lected.
Protein concentration was determined by Bradford assay
and 10–20 g of protein was loaded per well. Immunoblot-
ting was performed using the following antibodies: HA
(Clone 16B12, Covance), Flag (M2, Sigma), human HIF1
(Clone 241809, R&D systems), XIAP (2F1, Enzo), -actin
(AC-74, Sigma), K48-linked ubiquitin chains (#4289, Cell
Signaling), K63-linked ubiquitin chains (#5621, Cell Sig-
naling), ubiquitin (#3936, Cell Signaling), Ubc13 (#4919,
Cell Signaling), PARP (#9542, Cell Signaling). After wash-
ing with TBS-T, membranes were incubated with secondary
antibodies for 1 h at room temperature. Enhanced chemilu-
minescence (Pierce) was used to visualise the blots on Hy-
Blot CL autoradiography film (Denville Scientific).
Preparation of Histidine-tagged tandem ubiquitin binding en-
tities (His-TUBEs)
His-TUBEs were inducibly expressed in Escherichia coli
BL21Rosetta (Novagen) for 4 h at 37◦C. Cells were lysed by
sonication in PBS supplemented with protease inhibitors,
and the lysates were clarified by 20 min centrifugation at
10 000 rpm. His-TUBEs were purified with NiNTA beads
(Invitrogen) and eluted with PBS 100 mM Imidazole. His-
TUBES were then dialysed in 50 mM Tris pH 8.0, 150 mM
NaCl using 10 kDa cut-off dialyser-cassette (Pierce). Con-
centration of His-TUBES was calculated by SDS-PAGE
followed by coomassie staining against a known standard.
His-TUBE pull downs
For each pull down experiment a sub-confluent 10 cm plate
of mammalian culture cells was lysed in the presence of His-
TUBEs (3 M His-TUBEs, 50 mM Tris–HCl pH 8.0, 150
mMNaCl, 20mM imidazole, 1%NP-40). Lysates were son-
icated in a Biodisrupter Ultra-Sonic Waterbath (Diagen-
ode), and clarified by centrifugation at 4◦C for 10 min at
13 000 rpm.
His-TUBE complexes were incubated end-over-end for 1
h at 4◦C with 20 l packed volume Ni-NTA agarose beads.
Beads were washed 3× with wash buffer (50 mM Tris–HCl
pH 8.0, 150 mM NaCl, 20 mM imidazole, 1% NP-40), be-
fore being boiled in 1× SDS loading dye. Pull downs were
resolved by SDS-PAGE and analysed by immunoblotting
using specific antibodies.
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Cell viability assays
Cell viability was measured using Presto Blue assays, per-
formed according to the manufacturer’s protocol. Twenty
four hours after seeding, cells (5000 cells/well) were pre-
treated with inhibitors for 30 min before incubation at 1%
O2. The absorbance was recorded at 570 nm after 30min in-
cubation of cells with Presto Blue reagent. The cell viability
was expressed as a percentage relative to untreated controls.
Caspase activity assay
Cells were seeded into 96-well plates at a density of 5000
cells/well. Twenty four hours after seeding, cells were
treated as indicated and the caspase activity was determined
using Caspase-Glo assay (Promega) according to the man-
ufacturer’s protocol.
Ubiquitination assays
For ubiquitination assays, cells were lysed at room tem-
perature under denaturing conditions (8 M urea, 50 mM
Tris [pH 8.0], 300 mM NaCl, 50 mM Na2HPO4, 0.5%
NP-40, 1 mM PMSF, supplemented with protease in-
hibitors) and ubiquitinated material was recovered by ro-
tation with NiNTA-agarose (Invitrogen) or streptavidin-
agarose (Sigma), washed 3× with lysis buffer and analysed
by western blotting.
Quantitative reverse transcription-PCR
Total RNA was isolated using the Peqgold Total RNA Iso-
lation Kit (Peqlab) according to the manufacturer’s instruc-
tions. Reverse transcription with random and oligo(dT)
primers and MMLV reverse transcriptase (Quanta Bio-
sciences) was performed on 500 ng of total RNA.
Quantitative PCR data was generated on a Rotor-Gene
Q (Qiagen) using the following experimental settings: hold
50◦C for 3 min; Hold 95◦C 10 min; cycling (95◦C for 30 s;
58◦C for 30 s; 72◦C for 30 s with fluorescence measurement
for 45 cycles). All values were calculated relative to maxi-
mum hypoxic induction and normalised to RPL13A levels
using the Pfaffl method. Each cDNA sample was assayed in
duplicate and the results shown are averages derived from
three to four biological repeats with error bars indicating
the standard deviation.
Primers used were: RPL13A sense 5′-CCT GGA GGA
GAA GAG GAA AGA GA-3′, antisense 5′-TTG AGG
ACCTCTGTGTATTTGTCAA-3′; ANKRD37 sense 5′-
GTC GCC TGT CCA CTT AGC C-3′, antisense 5′-GCT
GTT TGC CCG TTC TTA TTA CA-3′; CAIX sense 5′-
CTTTGCCAGAGTTGACGAGG-3′, antisense 5′-CAG
CAA CTG CTC ATA GGC AC-3′; GLUT1 sense 5′-CTG
GCA TCA ACG CTG TCT TC-3′, antisense 5′-GCC TAT
GAG GTG CAG GGT C-3′; HIF1 sense 5′-CAT AAA
GTC TGC AAC ATG GAA GGT-3′, antisense 5′-ATT
TGA TGG GTG AGG AAT GGG TT-3′; HIF1 sense
5′-CAA GCC CCT TGA GAA GTC AG -3′, antisense
5′-GAG GGGCTAGGCCAC TAT TC-3′; PDK1 sense 5′-
AGTTCATGTCACGCTGGGTA-3′, antisense 5′-CAG
CTT CAG GTC TCC TTG GA-3′; VEGF sense 5′-CCT
GGT GGA CAT CTT CCA GGA GTA CC-3′, antisense
5′-GAA GCT CAT CTC TCC TAT GTG CTG GC-3′.
Chromatin immunoprecipitation (ChIP)
Proteins were cross-linked with formaldehyde for 10 min.
0.125 mMglycine was added, and cells washed with ice cold
PBS. Cells were lysed with lysis buffer (1% SDS, 10 mM
EDTA, 50 mMTris–HCl, pH 8.1, 1 mMPMSF), then soni-
cated in a Biodisrupter Ultra-SonicWaterbath (Diagenode)
(10 × 20 s cycles on high) to shear the genomic DNA and
clarified by centrifugation at 13 000 rpm at 4◦C for 10 min.
The supernatant was precleared with sheared salmon sperm
DNA and protein G-Sepharose beads (Sigma). The super-
natant was incubated with specific antibodies overnight (1
g per IP), and then antibody protein complexes were cap-
tured with protein G-Sepharose beads for 1 h. After an ex-
tensive wash step, the complexes were eluted with buffer
(100 mM NaHCO3, 1% SDS) and incubated with pro-
teinase K. DNA was purified by phenol chloroform extrac-
tion. Quantative PCR was performed on the purified im-
munoprecipitated DNA using specific primers. ANKRD37
HRE sense 5′-AAA CTC CCG CTT CTC CGT AA-3′;
ANKRD37HRE antisense 5′-TAAGTCAGTGGGCGT
GAG AG-3′; CAIX HRE sense 5′-GAC AAA CCT GTG
AGA CTT TGG CTC C-3′; CAIX HRE antisense 5′-AGT
GAC AGC AGC AGT TGC ACA GTG-3′.
Immunofluorescence
For immunofluorescence, cells were grown on coverslips
and treated as indicated prior to fixation by incubation
in 3.7% formaldehyde/PBS for 15 min. Cells were perme-
abilised in PBS-1% Triton X-100–0.05% Tween for 15 min
and then blocked in PBS–0.05% Tween supplemented with
10% BSA for 30 min. HIF1 antibody was diluted 1:100 in
1% BSA-0.5% Tween20–PBS incubated for 1 h. Secondary
antibody labelled with X-Red was purchased from Jack-
son Immunoresearch and used at 1:500. Cover slips were
mounted using Pro Long Gold mounting media.
RESULTS
HIF1 is ubiquitinated by XIAP
Control of HIF is primarily mediated bymodulating the ac-
cumulation and activity of the HIF1 subunit (1,2). HIF1
levels are predominantly regulated by Lys48-linked polyu-
biquitination by VHL, however alternative E3 ligases can
modulate the levels and activity of HIF1 independently
of the well-described VHL-dependent pathway (2). The X-
linked inhibitor of apoptosis (XIAP) belongs to the fam-
ily of IAP (inhibitor of apoptosis) proteins, and its best-
described role is as an inhibitor of caspases-3, -7 and -9
(10). However, in addition to its cytoprotective role, XIAP
also acts as an E3 ubiquitin ligase by virtue of its carboxy-
terminal RING domain (10). XIAP has been described as
a key signaling intermediate required for receptor activated
canonical and non-canonical NF-B (11), regulation of cell
motility (10), activation of MAPK/JNK (12), Wnt signal-
ing (13) and hypoxia-induced NF-B (14). We therefore in-
vestigated if XIAP might also function as an alternative
HIF1 E3 ubiquitin ligase that contributes to the HIF1-
dependent response to hypoxic stress. Ubiquitin pull down
assays reveal that XIAP depletion by siRNA resulted in
Nucleic Acids Research, 2017, Vol. 45, No. 16 9339
impaired HIF1 ubiquitination compared to cells trans-
fected with a non-targeting control (Figure 1A). To investi-
gate whether overexpression of XIAP altered HIF1 ubiq-
uitination HEK293 cells were co-transfected with plasmids
encoding HIF1 and His-tagged ubiquitin, in the pres-
ence or absence of exogenous XIAP. When HIF1 was ex-
pressed alone, polyubiquitination was observed, consistent
with HIF1 being a ubiquitinated protein (Figure 1B). The
levels of ubiquitin-modified HIF1 isolated in an ubiqui-
tin pull down were markedly increased with cotransfection
of XIAP with no decrease in the levels of the HIF1 pro-
tein being observed (Figure 1B). Co-expression of the best-
described HIF1 ubiquitin ligase VHL reduced total lev-
els of HIF-1, consistent with its known role in promot-
ing HIF1 proteasomal degradation. Polyubiquitination of
HIF1 was specific since XIAP did not promote the conju-
gation of ubiquitin chains to other regulators of the HIF
pathway; PHD1, PHD2, PHD3 or VHL (Supplementary
Figure S1A).
XIAP promotes the conjugation of Lys63-linked ubiquitin
chains to HIF1
XIAP can promote the formation both Lys63- and Lys48-
linked polyubiquitin chains depending on the substrate and
the E2 ubiquitin-conjugating enzyme (10). We therefore in-
vestigated which of these forms of ubiquitin chains were
conjugated to HIF1 by XIAP. A plasmid encoding biotin-
tagged HIF1 was transfected into HEK293 cells, together
with an expression vector encoding XIAP. HIF1 con-
jugates were isolated by streptavidin pull down and sub-
jected to immunoblot analysis using antibodies designed
to recognise specific ubiquitin chain linkages (Figure 1C).
Lys48-linked ubiquitin chains were observed conjugated to
HIF1, but no increase in the levels of these were seen when
XIAP was overexpressed (Figure 1C). In contrast, levels of
Lys63-linked ubiquitin chains associated with HIF1 were
markedly increased in cells expressing exogenous XIAP
(Figure 1C). The data indicate that XIAP promotes the
formation of the non-degradative Lys63-linked ubiquitin
chains onto HIF1, but does not affect the formation of
Lys48-linked chains.
Ubc13 activity is required for HIF1 Lys63 polyubiquitina-
tion
The formation of Lys63-linked ubiquitin chains is depen-
dent on Ubc13, the active subunit of an E2 ubiquitin conju-
gating enzyme complex (15). Cells were treated with two in-
dependent small molecule inhibitors of Ubc13, NSC697923
or BAY 11–7082, to investigate whether chemical inhibi-
tion ofUbc13 could prevent Lys63-ubiquitination ofHIF1
(16,17). Levels of Lys63-linked ubiquitin chains associated
with biotinylated HIF1 were markedly decreased in cells
treated with NSC697923 or BAY 11-7082, however total
levels of HIF1 remained constant (Supplementary Figure
S1B). These data indicate that HIF1 is modified by Lys63-
linked ubiquitin chains in a manner dependent on Ubc13
activity.
To investigate whether Ubc13 inhibition could alter the
ubiquitin status of endogenousHIF1we isolated ubiquitin
conjugates from hypoxic cells using tandem ubiquitin bind-
ing entities based on the ubiquitin binding domain of the
ubiquilin protein (UBQ-TUBEs). UBQ-TUBEs bind with
high affinity to Lys63- or Lys48-linked polyubiquitin chains
(18) and efficiently isolate ubiquitinated HIF1 for U2OS
cells treated with proteasomal inhibitor, MG132 (Supple-
mentary Figure S1C). Hypoxic U2OS cells were pretreated
with the Ubc13 inhibitor, NSC697923, then lysed in the
presence of UBQ-TUBEs (18). Cells treated with Ubc13
inhibitor had less ubiquitinated HIF1 as determined im-
munoblot following byTUBEpull down, indicating that the
total ubiquitinated pool of endogenous HIF1 in hypoxic
conditions was reduced when Ubc13 activity was inhibited
(Figure 1D).
To examine levels of endogenous Lys63-linked ubiquitina-
tion of HIF1 we prepared TUBEs based on the ubiquitin-
binding domain of TAB2 (TAB2-TUBEs) and used these
to isolate Lys63-linked ubiquitin conjugates from cells. The
UBD of TAB2 binds specifically and efficiently to Lys63-
linked ubiquitin chains and TAB2-TUBEs efficiently iso-
lated Lys63-linked ubiquitin conjugates from cells, as deter-
mined by immunoblot with a Lys63-linked ubiquitin chain
specific antibody (Supplementary Figure S1D). The bind-
ing of ubiquitin to the TAB2-TUBEs was specific as pull
down performed with TAB2 TUBES with point muta-
tions (T674A F675A) that disrupt the ubiquitin interac-
tion domain (TAB2-AA-TUBEs) did not purify any Lys63-
linked ubiquitinated proteins (Supplementary Figure S1D).
HIF1 was specifically isolated by TAB2-TUBE purifica-
tion from hypoxic cells, but not with TAB2-AA-TUBEs,
consistent with HIF1 being a Lys63-ubiquitinated pro-
tein (Supplemental Figure S1D). Cells treated with Ubc13
inhibitor had less Lys63-ubiquitinated HIF1 as deter-
mined by TAB2-TUBE pull down, indicating that Ubc13
is required for Lys63-dependent ubiquitination of HIF1
(Figure 1E). To determine if these effects were due to
Lys63-dependent ubiquitination impacting on the VHL-
dependent HIF1 degradation pathway UBQ-TUBE pull
downs were performed on VHL-deficient RCC4 cells which
have constitutively high levels of HIF1. Levels of ubiqui-
tinated HIF1 are suppressed by Ubc13 inhibition in the
absence of VHL, indicating that this is a distinct parallel
regulatory pathway (Supplementary Figure S1E). Together
these data indicate thatHIF1 is conjugated to Lys63-linked
ubiquitin chains in cells and that XIAP and Ubc13 are im-
portant for the polyubiquitination of endogenous HIF1.
Lys63-linked ubiquitination of HIF by XIAP/Ubc13 pro-
motes expression of hypoxia-induced gene products
To examine the role of XIAP-mediated ubiquitination of
HIF1 in the expression of hypoxia-responsive target genes,
we performed quantitative real time PCR analysis of the
expression of HIF1 target genes in cells depleted of XIAP.
U2OS cells transiently transfected with either control siR-
NAs or siRNAs designed to reduce XIAP expression were
subjected to hypoxia for the indicated time points (Figure
2A). RNA was isolated from these cells and was used to
quantitate the transcript levels of the hypoxia-responsive
genes; CAIX, ANKRD37, GLUT1, PDK1 and VEGF. As
expected, exposure to low oxygen resulted in an increase in
9340 Nucleic Acids Research, 2017, Vol. 45, No. 16
40
130
100
180
130
100
180
70
55
130
100
130
100
180
70
HA-HIF1α
n
o
Ci
s
P
AI
Xi
s
XIAP
N
i-N
TA
 P
ul
l D
ow
n
Ly
sa
te
siRNA : 
Actin
n
o
Ci
s
His-Ub- + +
A B
C
130
100
180
- + - +
Input NPD E
D
HIF1α
HIF1 α
Hypoxia
-
-
-
+
-
-
+
+
-
+
+
X
+
+
V
His-Ub
HA-HIF1α
Flag E3
Ub
HA-HIF1α
-
-
-
+
-
-
+
+
-
+
+
X
+
+
V
His-Ub
HA-HIF1α
Flag E3
Flag XIAP
Flag VHL
Actin
Ub
Actin
Flag XIAP
NBT-HIF1α
-
-
+
-
+
+
130
100
180
70
NBT-HIF1α
Flag XIAP
-
-
+
-
+
+
NBT-HIF1α
Flag XIAP
-
-
+
-
+
+
NBT-HIF1α
Flag XIAP
130
100
180
70
55
130
100
UBQ-TUBEs+ ++ +
- + - +
+ ++ +
++- - ++- - NSC
TAB2-AA-TUBEs+ -- -
+-- - NSC
++- - TAB2-TUBEs
Hypoxia- + ++
+ -- -
+-- -
++- -
- + ++
HIF1α
HIF1α
Actin
Input NPD
130
100
130
100
180
130
100
180
40
K63-Ub K48-Ub
70
55
40
35
25
15
40
35
40
Figure 1. XIAP ubiquitinates HIF1. (A) U2OS cells were transfected with siRNA oligonucleotides and His-tagged ubiquitin as indicated. Lysates were
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Figure 2. Inhibition of Lys63-linked ubiquitination of HIF1 suppresses HIF1-dependent gene expression. (A) Quantitative RT–PCR analysis of CAIX,
ANKRD37,Glut1, PDK1 andVEGFmRNAprepared fromU2OS cells expressing siRNAs targetingXIAP,HIF1 or a control siRNA, and subsequently
exposed to 1%O2 for 24 h. All values are normalised toRPL13AmRNAand fold change calculated from control samples prepared in normoxic conditions.
(B) Quantitative RT–PCR analysis of CAIX, ANKRD37, Glut1, PDK1 and VEGF mRNA prepared from U2OS cells pre-treated with the indicated
concentrations of NSC697923 for 30 min before being exposed to 1% O2 for 7 h. All values are normalised to RPL13A mRNA and fold change calculated
from normoxic controls. Significance calculated relative to hypoxic controls using a one-way ANOVA using the Dunnett multiple comparison test.
expression of all of these genes, as compared to control (Fig-
ure 2A). In cells transfected with siRNA to deplete XIAP
the levels of HIF target genes were reduced, although not
to the extent we observed with siRNAs depleting HIF1
mRNA. These data are consistent with XIAP modulating
the expression HIF-dependent genes (Figure 2A).
The importance of Lys63-linked ubquitination for the ex-
pression of HIF1-dependent gene expression examined by
using specific chemical inhibitors of Ubc13. Pre-treatment
of U2OS cells with NSC697923 suppressed the hypoxia-
induced expression of each of the HIF-target genes, con-
sistent with Ubc13 activity being important for the expres-
sion of HIF-target genes (Figure 2B). Similar results were
observed using a second inhibitor of the Lys63-linked ubiq-
uitination pathway, BAY 11–7082 (Supplementary Figure
S2A). Experiments were then performed using siRNA to
deplete Ubc13 levels. Ubc13 siRNA efficiently reduced lev-
els of Ubc13 protein in U2OS cells as measured by western
blot (Supplementary Figure S2B). Depletion of Ubc13 re-
sulted in a decrease in the expression of hypoxia-induced
HIF target genes (Supplementary Figure S2C). HEK293
and PC-3 cells pretreated with either NSC697923 or BAY
11-7082 also had reduced hypoxia-induced HIF-dependent
gene expression, indicating that the Lys63-linked ubiqui-
tination pathway is important for the HIF-dependent re-
sponse in different cell lines (Supplementary Figure S2D).
HIF1 protein and transcript levels are not altered byUbc13-
dependent Lys63-linked ubiquitination
Lys63-linked polyubiquitination is necessary for the acti-
vation of the NF-B family of transcription factors in re-
sponse to several stimuli (19,20). Indeed, both NSC697923
and BAY 11-7082 have been shown to prevent NF-B acti-
vation in numerous cell lines through inhibition of Ubc13-
dependent Lys63-linked ubiquitination of the components
of the NF-B signal transduction cascade (16,17,21). As
both HIF1 andHIF1 are direct NF-B target genes (22–
24) we investigated whether Ubc13 inhibition was alter-
ing HIF activity by altering the levels of HIF1 or HIF1
mRNA. HIF1 and HIF1 mRNA levels were analysed
by quantitative RT-PCR (qRT-PCR), using RNA puri-
fied from U2OS cells treated with NSC697923 or BAY 11-
7082 (Supplementary Figures S3A and S3B). Inhibition of
Ubc13 revealed no significant differences in either HIF1
or HIF1 mRNA levels, indicating that the role of Lys63-
linked polyubiquitin in regulating HIF is not due to an ef-
fect on HIF1 or HIF1 mRNA production or stability,
but most likely Ubc13 inhibitors exert their effects on the
HIF pathway post-transcriptionally (Supplementary Fig-
ures S3A and S3B).
The primary mechanism for controlling HIF1 activity is
through the protein levels of the HIF1 subunit (2). To in-
vestigate whether Ubc13 inhibition was altering the protein
levels of HIF1 following hypoxia, U2OS cells were pre-
treated with NSC697923 and incubated at low oxygen for
the indicated time points (Figure 3A). No significant de-
crease in the oxygen-dependent accumulation of HIF1, or
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total levels of HIF1 was observed after Ubc13 inhibition
in hypoxia (Figure 3A and Supplementary Figures S3A and
S3B).
We then examined whether XIAP or Ubc13 depletion
altered the total levels of HIF1 following hypoxic stress
in U2OS cells transfected with siRNAs targeting XIAP or
Ubc13 and exposed to hypoxia for the indicated times. No
change was observed in the levels of HIF1 stabilised by
hypoxic stress in the presence or absence of XIAP or Ubc13
(Figure 3B and C). These results suggest that knockdown
of XIAP or chemical inhibition / depletion of Ubc13 does
not alter theHIF1 transcriptional response by altering total
levels of HIF1 stabilised by low oxygen.
Lys63-linked ubiquitination controls HIF1 subcellular lo-
calisation in hypoxia
To explore how Lys63-linked polyubiquitination alters the
activity of HIF we performed subcellular fractionation ex-
periments to investigate whether Ubc13 inhibition alters
the subcellular localisation of stabilised HIF1 in hypoxic
cells. Nuclear and cytoplasmic extracts were prepared from
U2OS cells pre-treated with NSC697923 following hypoxic
stress and immunoblotted for HIF1 levels (Figure 3D).
HIF1 was observed in the nuclear fraction in low oxy-
gen conditions, however, the levels of nuclear HIF1 are
lower in cells treated with NSC697923 (Figure 3D). No ef-
fect was seen on the related HIF family member HIF1.
We did not observe an increase of HIF1 in the cytoplas-
mic fraction in these experiments as a result of HIF1 con-
centration being below the level of detection. To enable de-
tection, HIF1 was immunoprecipitated from cytoplasmic
extracts and subsequently immunoblotted. An increase in
cytoplasmic HIF1 was observed in hypoxic cells treated
with NSC697923, consistent with the decrease of HIF1 in
the nucleus (Supplementary Figure S4A). In addition, we
examined HIF1 levels in cells transfected with siRNA to
deplete Ubc13 or XIAP protein levels. A decrease in the lev-
els of nuclear HIF1 was detected in the absence of Ubc13
(Figure 3E and F). Interestingly, the data reveal that a pro-
portion of Ubc13 also translocates to the nucleus in hy-
poxic conditions, suggesting a nuclear role for Ubc13 in hy-
poxic cells (Figure 3F). To complement biochemical sub-
cellular fractionation experiments, HIF1 localisation was
measured by immunofluorescence following hypoxic stress.
U2OS cells pre-treated withNSC697923 and exposed to hy-
poxia for 3 hours were fixed and stained using a specific
HIF1 antibody. In hypoxic U2OS cells, HIF1 is read-
ily observed in the nucleus as confirmed by co-localisation
with a nuclear stain (Supplementary Figure S4B). In cells,
pre-treated with NSC697923 a dose dependent reduction in
the nuclear levels of HIF1 was observed, consistent with
biochemical subcellular fractionation data (Supplementary
Figure S4B).
Ubc13 inhibition impairs HIF1 promoter occupancy ofHIF
target genes
Our data reveals that inhibition of Lys63-linked polyubiqui-
tination of HIF1 alters the transactivation of HIF target
genes, but does not alter total levels of HIF1 accumulation
in low oxygen conditions. To understand how disruption to
the Lys63-linked polyubiquitin pathway alters HIF target
gene expression we examined the levels of HIF1 associ-
ated with the promoters of target genes in the presence of
NSC697923. Chromatin immunoprecipitation (ChIP) as-
says were used to examine the occupancy of HIF1 present
at the promoters ofHIF target genesANKRD37 andCAIX
in hypoxic U2OS cells (Figure 4A). A reduction in the lev-
els of HIF1 associated with the promoters of HIF tar-
get genes was observed in hypoxic cells pre-treated with the
NSC697923 (Figure 4A). These data suggest that inhibition
of Lys63-linked polyubiquitin compromises gene occupancy
by HIF1, despite the total cellular levels of HIF1 being
unaltered (Figure 4A).
Ubc13 activity is necessary for HIF1 nuclear retention
Movement of transcription factors to and from the nu-
clear compartment depends on the presence of targeting se-
quences in the protein, which are recognised by specific nu-
clear transport receptors and nuclear export proteins. Tran-
scription factors, such as HIF1, can be regulated by con-
trol of their nuclear import, export or a combination of both
(25).
To investigate, mechanistically, how HIF1 nuclear lo-
calisation is altered we tested whether Ubc13 inhibition
could promote the export of constitutively stabilised, nu-
clear HIF1, where the VHL binding sites, proline 402 and
564, have been mutated to alanine (HIF1 P>A). As ex-
pected HIF1 P>A was efficiently expressed and was pre-
dominantly found in the nucleus of transfected cells (Fig-
ure 4B and C). Cells treated with the Ubc13 inhibitor
NSC697923 has less nuclear HIF1 P>A than untreated
controls, despite the total level of the exogenous protein re-
maining unchanged. These data indicate that Lys63-linked
polyubiquitination-dependent nuclear retention of HIF1
does not result from effects on VHL mediated HIF1
degradation (Figure 4B and C).
Export of HIF1 from the nucleus is mediated by thema-
jor nuclear export pathway dependent on the exportin pro-
tein, Crm1 (26). To examine the role of Lys63-linked polyu-
biquitination in the export of HIF1 the well-described
Crm1 inhibitor, leptomycin B, was used (27). Nuclear ex-
tracts were prepared from hypoxic U2OS cells pre-treated
with NSC697923 and leptomycin B as indicated (Figure
4D). Hypoxic U2OS cells treated with NSC697923 had de-
creased levels of nuclear HIF1, consistent with previous
observations. However, in cells pre-treated with leptomycin
B the levels of nuclear HIF1 induced by hypoxic stress
were insensitive to inhibition of the Lys63-linked polyu-
biquitin pathway (Figure 4D, Supplementary Figure S4D).
Lys63-linked polyubiquitin of HIF1 therefore acts to pre-
vent its nuclear export rather then being required for nuclear
import.
Ubc13 inhibition sensitises cells to hypoxic stress
As the HIF pathway is an attractive target for numerous
human disease states we investigated whether Ubc13 inhi-
bition could alter viability of hypoxic cells. We therefore
titrated the Ubc13 inhibitor, NSC697923, into U2OS and
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Figure 4. Ubc13 activity is necessary for HIF1 nuclear retention. (A) ChIP assays using Control IgG and HIF1 antibodies were performed on cell
extracts fromU2OS cells pre-treated with 2MNSC697923 for 30 min before being exposed to 1% O2 for 3 h. Immunoprecipitated DNAwas analysed by
qPCR using the indicated primer pairs and normalised to input genomic DNA. (B and C) U2OS cells were transfected with HA-HIF1 (P402A, P564A)
or empty vector and treated with 2 M NSC697923 for 3 h. Whole cell lysates (B) or nuclear and cytoplasmic extracts (C) were prepared. Extracts were
analysed by immunoblotting using the indicated antibodies. (D) Cytoplasmic and nuclear extracts were prepared from U2OS cells treated with 2 M
NSC697923 and 5 ng/ml Leptomycin B as indicated before being exposed to 1% O2 for 3 h. P-values are significant according to the Student’s t-test; *P
< 0.05, **P < 0.01.
PC-3 cells and investigated their viability after 24 h in either
normoxic or hypoxic conditions. Cells cultured in hypoxic
conditions had increased sensitivity to NSC697923, with a
decrease in the viability observed at much lower concen-
trations of the Ubc13 inhibitor (Figure 5A and B). To de-
termine whether changes in the levels of apoptosis were re-
sponsible for the loss of viability in hypoxic cells treatedwith
the Ubc13 inhibitor and measured the activity of caspases-
3/7, the executioner caspases activated in apoptotic cell
death. Hypoxic cell treated with NSC697923 had increased
caspase activity compared to untreated hypoxic cells, indi-
cating a higher level of apoptosis (Figure 5C).Western blots
were performed to examine the levels of the caspase-3 tar-
get, PARP. The data indicate higher levels of PARP cleav-
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Figure 5. Hypoxic cells are more sensitive to Ubc13 inhibitors. (A) U2OS
or (B) PC-3 cells were pretreated with the indicated concentrations of
NSC697923 before being exposed to 1% O2 for 24 h. Cell viability was
measured by Presto Blue assay and values normalised to untreated con-
trols. (C) U2OS treated as in with 2uM NSC697923 (A). Caspase activity
was determined by Caspase-Glo assay and values normalised to normoxic
controls. Error bars represent standard deviation. P-values are significant
according to the Student’s t-test; *P < 0.05, **P < 0.01.
age in hypoxic cells treated withNSC697923 consistent with
higher levels of active caspase-3 (Supplemental Figure S5).
These data indicate that the conjugation of Lys63-linked
polyubiquitin chains is important for the adaptive cellular
response to hypoxia.
Our data collectively reveal that the formation of Lys63-
linked ubiquitin chains to HIF1 promotes the full expres-
sion of HIF target gene expression in hypoxic cells (Figure
6). Conjugation of Lys63-linked ubiquitin chains to HIF1
by XIAP controls HIF1 activity, not by altering its stabil-
ity, but by controlling nuclear export of HIF1 in a Crm1
dependent manner therefore controlling its ability to drive
the expression of target genes.
DISCUSSION
The results of the present study indicate that the full ac-
tivation of the HIF-dependent transcriptional response
requires the action of E3 ubiquitin ligases that conju-
gate Lys63-ubiquitin chains to HIF1. Our data, using
small-molecule inhibitors and specific siRNAs targeting the
ubiquitin-conjugating enzyme, Ubc13, demonstrate that
the hypoxia-dependent expression of HIF1 target genes is
suppressed when the Lys63-ubiquitin conjugation pathway
is disrupted.
We have identified XIAP as a key ubiquitin E3 ligase re-
sponsible for Lys63-linked ubiquitination of HIF1. XIAP-
dependent conjugation of Lys63-linked ubiquitin chains
correlates with elevated HIF1 activity and like inhibition
of Ubc13 alters HIF1 subcellular localisation. Our data
suggest that XIAP is involved in a parallel pathway respon-
sible for controlling the level of the HIF1 dependent hy-
poxic response. XIAP, a well-described suppressor of cell
death has also been shown to be highly overexpressed in
many forms of cancer. Both HIF1 and XIAP expression
have been correlated with the progression or severity of neo-
plastic disease. A longitudinal study of patients with acute
myeloid leukemia (AML) revealed a correlation between
poor prognosis and elevated XIAP levels (28). Interestingly,
other studies have identified a correlation between HIF1
levels and poor prognosis in AML, perhaps providing indi-
rect evidence of a link between these proteins contributing
to disease (29).
Multiple roles for Lys63-linked polyubiquitylation in im-
mune responses have emerged in recent years, including reg-
ulation of NF-B, TGF and MAPK signaling, indicating
the importance of this regulatory strategy (30). Our data in-
dicates that Ubc13 plays a critical role in the HIF pathway,
which also has crucial roles in the immune response (31).
Intriguingly, data obtained in experiments in Ubc13 condi-
tional knockout mice revealed that Ubc13 as a crucial reg-
ulator of hematopoiesis, a developmental process in which
HIF signaling has a critical role (32,33).
Inhibition of the formation of Lys63-linked ubiquitin
chains on HIF1 causes a decrease in HIF target gene
expression in part due to preventing nuclear retention of
HIF1 and thus blocking its association with HIF target
genes. Our data indicates that inhibiting Lys63-linked polyu-
biquitination of HIF1 accelerates the nuclear export of
HIF1 in a Crm1-dependent manner. The control of nu-
clear localisation of proteins by non-degradative polyubiq-
uitination has been previously described and our data may
indicate a conserved mechanism through which this post-
translational modification can alter the subcellular locali-
sation of protein substrates (34,35). In silico prediction of
ubiquitination sites on the HIF1 protein reveals that the
four lysine residues (Lys625, Lys629, Lys636 and Lys649) sur-
rounding, or within, the atypical Crm1-dependent nuclear
export sequence of HIF1 are likely to bemodified by ubiq-
uitin to a medium or high confidence interval (26) (http:
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Figure 6. Model of HIF1 regulation by XIAP and Ubc13.
//www.ubpred.org/). The addition of ubiquitin chains to or
near the nuclear export sequence may prevent the interac-
tion with Crm1, and suggest that removal of these chains
by an unknown deubiquitinating (DUB) enzyme may be
required to facilitate HIF1 nuclear export (Figure 6). In-
triguingly, our subcellular fractionation studies also reveal
that Ubc13 enters the nuclear compartment under condi-
tions of hypoxic stress where it could potentially target mul-
tiple factors. XIAP does notmove to the nucleus in hypoxia,
however subcellular fractionation experiments performed
in the presecnce of the nuclear export inhibitor leptomycin
B, demonstrate that a proportion of the protein shuttles be-
tween the nucleus and cytoplasm, indicating a nuclear role
for XIAP (Supplementary Figure S4C).
Our findings indicate that hypoxic cells are sensitive to
Ubc13 inhibition. This suggests that the Lys63-linked ubiq-
uitination pathway is important for the cellular response to
hypoxia, either purely through targeting HIF1, or by tar-
geting multiple proteins in this stress response. Studies from
the yeast, Saccharomyces cerevisiae, suggest that Lys63-
linked ubiquitination is critical in the oxidation-dependent
signaling response, perhaps indicating a conserved role for
Lys63-linked ubiquitination being a key post translational
modification in stress response pathways (36).
The data demonstrating the requirement of Ubc13 activ-
ity in the HIF-dependent hypoxic response indicates that
targeting the Lys63-linked ubiquitination pathway may rep-
resent a potential therapeutic target in clinical pathologies
with aberrant HIF activity. Indeed, there is great interest
in targeting the components of the ubiquitin conjugation
pathway in disease and chemical inhibitors of the proteaso-
mal and non-degradative ubiquitin pathways are being de-
veloped as potential therapeutics (37).
Our results suggest that Ubc13 inhibition and knock-
down have a more pronounced effect on the expression of
HIF target gene expression suggesting that alternative E3
ubiquitin ligases also target HIF1 Lys63-ubiquitination.
Indeed, both TRAF6 and STUB1 have been previously
demonstrated to conjugate Lys63-linked ubiquitin chains to
the HIF1 protein (38,39). Collectively, these data provide
further mechanistic understanding into the regulation of
theHIF-dependent transcriptional response to hypoxia. In-
sights into how this important transcription factor is regu-
lated advance our knowledge into how to target this signal-
ing pathway in disease.
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